Robert G Price
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 16, 2026
Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial.Atul Gupta, Isabelle J Pouliquen, Wanda Phipatanakul
|May 05, 2022
Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab.Ian D Pavord, Roland Buhl, Monica Kraft
|Jan 17, 2022
Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET.Mark C Liu, Elisabeth H Bel, Oliver Kornmann
|Jun 26, 2021
Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).Wendy C Moore, Oliver Kornmann, Marc Humbert
|Jan 21, 2021
Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing.Nicky Best, Robert G Price, Isabelle J Pouliquen
Pageof 1
